Wang J have demonstrated that patients with refractory/relapsed acute B lymphoblastic leukemia (B-ALL) exhibit a significant increase in TNF-α levels following CAR-T cell therapy, with peak serum levels correlating with CRS severity [52]. This evidence concerns the gene TNF and congenital rubella syndrome.